SEARCH

SEARCH BY CITATION

The below article in Volume 157, Supplement 1 of Clinical & Experimental Immunology contained errors:

  • • 
    Jorquera JI. Flebogamma® 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy. Clinical & Experimental Immunology 2009; 157 (Suppl. 1): 17–21.

Page 20 (second line of the second paragraph of the Viral safety studies section), should have said ‘(4 to ≥6 log10 reduction)’ rather than ‘(4 to =6 log10 reduction)’.

Page 20 (fourth line of the third paragraph of the Viral safety studies section), should have said ‘(range 1.3 to ≥5.3 log10)’ rather than ‘(range 1.3 to =5.3 log10)’.